Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic colorectal cancer
Hiroyuki Arai, Andrew Elliott, Joshua Millstein, Joanne Xiu, Fang‐Shu Ou, Federico Innocenti, Jingyuan Wang, Francesca Battaglin, Priya Jayachandran, Natsuko Kawanishi, Shivani Soni, Wu Zhang, Davendra Sohal, Richard M. Goldberg, Michael J. Hall, Aaron J. Scott, Moh’d Khushman, Jimmy J. Hwang, Emil Lou, Benjamin A. Weinberg, A. Craig Lockhart, Anthony F. Shields, Jim Abraham, Daniel Magee, Phillip Stafford, Jian Zhang, Alan P. Venook, W. Michael Korn, Heinz‐Josef Lenz
Topics & Concepts
Neurofibromin 1BiologyColorectal cancerPTENKRASCancer researchGene expression profilingOncologyCancerCDKN2AInternal medicineNeurofibromatosisPI3K/AKT/mTOR pathwayGene expressionMedicineGeneticsGeneSignal transductionNeurofibromatosis and Schwannoma CasesColorectal Cancer Treatments and StudiesPancreatic and Hepatic Oncology Research